Pat Adams (@PathologyPat) header
Pat Adams (@PathologyPat) profile picture

Product Development New England, Naveris, NavDx, minimal residual disease monitoring in head and neck cancer

Hartford, CT
Joined September 2018
Photo by Pat Adams (@PathologyPat)Photo by Pat Adams (@PathologyPat)Photo by Pat Adams (@PathologyPat)Photo by Pat Adams (@PathologyPat)Photo by Pat Adams (@PathologyPat)Photo by Pat Adams (@PathologyPat)Photo by Pat Adams (@PathologyPat)Photo by Pat Adams (@PathologyPat)Photo by Pat Adams (@PathologyPat)Photo by Pat Adams (@PathologyPat)
Pat Adams retweeted
Why does prior #Sepsis exacerbate subsequent infection injury? doi.org/10.1172/jci.insight.… Rachel L. Zemans & team @UMich show that primary sepsis reprograms bone marrow mononcytes to promote #LungInjury through durable changes in epigenetics and bone marrow progenitors. These changes in monocytes result in a neutrophil-like inflammatory phenotype that is linked to more severe disease and worse outcomes.
6
24
1,273
Pat Adams retweeted
Latest #CDlab paper on BioRxiv: biorxiv.org/content/10.64898… Here, Tor Eriksson developed a first method to quantify the strength of electro-osmotic flow in nanopores - super useful to apply in e.g. nanopore protein sequencing. All backed up by simulations by Chenyu Wen
8
59
2,527
A Virtual Pediatric Pathology Atlas is shared in this website luriechildrens.org/en/specia…
2
13
36
1,696
As the U.S. stands on the brink of losing its measles elimination status, here are a few facts to keep in mind amid the misinformation about how we got here:
9
46
2
88
2,553
How does leukaemia develop? 🩸 How long does it take? ⏳ 🌟 Our paper, started back when I was a PhD student in @jrblundell’s lab, is out today in @Nature 🌟 Yearly blood samples from women who developed AML in later life let us trace it back decades 👇 doi.org/10.1038/s41586-026-1…
16
92
14
300
19,901
Pat Adams retweeted
The HPV vaccine is eliminating cervical cancer Yes Read it again
Reminder that vaccines work!!
18
170
1
612
5,111
Pat Adams retweeted
We are excited to share our first nanopore sequencing study, now published in @NatureComms! We developed a deep learning-based method for accurate tRNA classification, absolute quantification, and single-molecule detection of RNA modifications. nature.com/articles/s41467-0…
1
25
1
106
6,265
Pat Adams retweeted
New preprint! We built an AI agent to analyze a massive single-cell atlas of 22 pediatric solid tumor types, finding ectopic neuronal gene expression in fusion-driven sarcomas. This pointed us to new cell surface targets, validating NPTXR in Ewing sarcoma! biorxiv.org/content/10.64898…
2
7
24
1,848
I asked Fable 5.2 for a film about the life of a T cell, immune cells I study. It wrote the script, fact-checked the immunology, built every cell in Blender, rendered 12,480 frames & added the narration & score! I am stunned by the beauty of this 8 minutes 40 seconds video!🥹😍
78
183
22
1,364
61,471
Up to 50 people will receive $70k to give away, as microgrants, to create new scientific fields. Good opportunity!
BIG NEWS! For the past few years, we've given scientists budgets so they can fund their peers with small, fast grants. Today, we're going bigger. We're opening up a call to find and fund emerging "field builders"—people with the ambition and curiosity to kickstart a new field of science and technology. You'll get a budget of $70,000 to regrant (up to $10,000) out to projects and ideas and join a community of explorers. Do you have an idea for a new field of science that *should* exist? Please apply!
1
17
110
8,016
Thank you Cancer Cytopathology for caffeinating me during the ASC mtg!!! 🤣 ☕️😍 ☕️
3
9
1
59
1,458
Chronic antibody-mediated rejection (#CAMR) is a leading cause of late kidney allograft failure and shares features of chronic immune activation with systemic #autoimmune diseases. 💡 In this @sigtrans_sttt article, scientists link circulating CAMR immune remodeling to a spatially organized CXCL12-CXCR4 fibroblast-immune niche and suggest that elements recur across alloimmune and autoimmune inflammation. 🔗 go.nature.com/4izVUxg
1
6
1
9
758
Interested in medical editing and publishing? The @JAMAOto Editorial Fellowship offers early-career faculty hands-on experience in peer review, manuscript evaluation, and editorial decision-making. 🔗 Apply here: ja.ma/4eMAFWw
3
4
475
This is a simple method to make "bacterial chimeras" (or trimeras) by moving ~2 million bases of DNA between bacteria in a single step. The method is called ACE, or Additive Conjugative-CAST Engineering. It's described in a new paper from Kaihang Wang's group at Caltech. They used this method to make, in one case, an organism with 4.6M bases of DNA from E. coli DH10B, 2M bases of DNA from Syn61 (a recoded strain of E. coli) and about 900kb from Shigella (meaning that this works across bacterial genera.) When I joined Caltech in 2018 to start my PhD, I was actually the first graduate student in Kaihang’s lab! I remember unboxing the equipment, getting the new pipettes out of the box, and installing the DNA sequencing machine. My bench was like two rows down from David Baltimore's group. This is the first project talked about when I joined, meaning that they've been working on this for at least the last 8 years. The way it works is that you have a donor strain and a recipient strain. You decide which DNA from the donor you want to transfer, and you flank that sequence with two bits of DNA, called CassetteSTART and CassetteEND. The donor is also engineered to express a helper plasmid, which encodes the machinery needed to move the DNA to the other strain via conjugation. Once the DNA moves into the recipient strain, a *second* helper plasmid splices it into a chosen location in the genome (via a CRISPR-associated transposase.) They use this simple approach to move up to 2 million bases of DNA in a single step. When they tested this on a 1 million-base strand of DNA, they got 1,000 successful colonies per experiment. (Meaning this works REALLY well.) Across three target sites, 98.1–99.7% of mapped insertions were at the intended site, too. And when they did RNA sequencing on these chimeras, they found that all the genes from all the donors were expressed. So why is this useful? Well, we can already move large segments of DNA, but DNA is fragile and can shear. You can order oligos or genes and assemble big sequences, but that takes a lot of time and money. With this tool, you could instead just identify a biosynthetic pathway in a cell and transfer it into a strain that’s easier to grow or use for biomanufacturing. This is a cheaper, more scalable way to "port" capabilities between cells. (But only bacteria of relatively closely-related genera for now.) This also works with synthetic DNA. Theoretically, then, you could "install" DNA into a cell and then use that strain as a sort of perpetual donor to transfer to other organisms, instead of rebuilding and re-transforming cells each time. I'm sure this will have other, as-yet-unseen uses as well.
4
20
110
6,266
Pat Adams retweeted
Love this!!! 🙌 #Fellows and #Residents, make sure to check it out! 👏@ja_ocejo #ASCOconnection 👉Excellent review of how to learn efficiently when every disease type has an encyclopedia’s worth of treatment options to navigate! 😅 #MedEd #MedX @IMG_Oncologists @ASCOTECAG @OncMedEdCoP @PallOncCoP @ASPIRE_CoP @healthpolicycop
📚 Recently wrote this piece for #ASCOConnection on learning during oncology fellowship—and how to keep building those skills beyond training. A lot of it comes from advice I’ve picked up from mentors and attendings along the way, plus a few lessons from figuring out what has worked (and not worked) for me. Hope it’s helpful to other fellows navigating the same process! 🔗 connection.asco.org/do/build… #MedEd #HemeOnc #OncTwitter
9
38
2,121
tRIBO-seq distinguishes ribosome-associated tRNAs and total tRNAs using nanopore sequencing. @EvaMariaNovoa @NovoaLab nature.com/articles/s41592-0…
1
12
1
69
5,968
Pat Adams retweeted
Review @SciImmunology @EricVivier1 Programming immunity in situ: A new frontier of in vivo cell engineering science.org/doi/10.1126/scii… 🇫🇷
1
20
1
62
3,729
New online! Small variant calling in the era of long-read sequencing dlvr.​it/TW0GMJ
1
22
63
6,886
Words and phrases we use in pathology: Do they actually make sense to trainees? 🤔 Is it time to rethink how we communicate? Is it time to update our language to make pathology more accessible & understandable to the next generation? #PathX #PathTwitter
4
8
1
39
2,123
Pat Adams retweeted
Notable: Researchers from 50 institutions collaborate to find a biomarker that has the potential to detect ovarian cancer very early, even pre-malignant A cancer not detected by the Galleri test. An extracellular vesicle long non-coding RNA @NatureMedicine nature.com/articles/s41591-0… nature.com/articles/s41591-0…
14
85
7
341
28,357